Analysis of Novel Positioning Sensor-assisted Postoperative Position Correction and Effective Prone Time Recorded in Patients With Different Prone Times After Macular Hole Surgery

NCT ID: NCT05757349

Last Updated: 2023-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2024-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Idiopathic macular hole (IMH) is a fundus disease without clear etiology, most often seen in healthy women over 50 years of age, and is often associated with ocular manifestations such as loss of central vision and visual distortion. It is often associated with loss of central vision, visual distortion, and other ocular manifestations. It is currently treated by vitrectomy combined with internal limiting membranes (ILM) peeling followed by gas filling. A strict prone position for a certain period of time after surgery has a positive effect on the healing of the macular fissure. The need for a strict prone position after IMH has been demonstrated in previous studies (especially when the IMH diameter is \>400 μm). However, due to the anti-human mechanics of the face-down position, patient comfort, sleep quality and quality of life are greatly compromised. Therefore, this study designed a smart head position monitoring device to assist patients in maintaining the correct position and recording the effective position time. The study was conducted to determine the shortest prone position time based on macular fissure closure, to minimize the adverse effects of postoperative position, and to obtain the maximum recovery of visual acuity and visual field.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Macular Hole Effective Prone Time

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Face-down position time 1-day group

Postoperative face-down position of subjects wearing the novel positioning sensor device for 1-day.

Group Type EXPERIMENTAL

Face-down position time 1-day

Intervention Type BEHAVIORAL

Postoperative face-down position of subjects wearing the novel positioning sensor device for 1-day.

Face-down position time 3-day group

Postoperative face-down position of subjects wearing the novel positioning sensor device for 3-day.

Group Type ACTIVE_COMPARATOR

Face-down position time 3-day

Intervention Type BEHAVIORAL

Postoperative face-down position of subjects wearing the novel positioning sensor device for 3-day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Face-down position time 1-day

Postoperative face-down position of subjects wearing the novel positioning sensor device for 1-day.

Intervention Type BEHAVIORAL

Face-down position time 3-day

Postoperative face-down position of subjects wearing the novel positioning sensor device for 3-day.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years or older;
* Patients diagnosed with IMH;
* Patients requiring face-down position after vitrectomy combined with ILM peeling and C3F8(14%) gas filling; Tolerated face-down position after surgery;
* Agreed to the study protocol.

Exclusion Criteria

* Myopia greater than or equal to -6.0 D; Eye axis length (AL) greater than 26.0mm;
* Trauma, macular edema, macular degeneration, and other secondary MH with clear etiology;
* Previous history of internal eye surgery in the operated eye;
* Patients with local or systemic other diseases significantly affecting visual function;
* Those who cannot maintain face-down position after surgery due to systemic factors, etc.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tianjin Medical University Eye Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bojie Hu

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tianjin medical university eye hosipital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bojie Hu

Role: CONTACT

13612130943

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bojie Hu

Role: primary

13612130943

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TianjinMUEHhbj456

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.